BizJournals Portfolio

Ambit Biosciences Corporation

Company Information

4215 Sorrento Valley Blvd
San Diego, CA
United States
Phone: (858) 334-2100
Fax: (858) 334-2199

Scott Salka

ambitbio.com

Industry: Healthcare


Overview

Ambit Biosciences is combining the power of our KinomeScan kinase profiling technology with an innovative licensing strategy and a history of kinase expertise to discover, optimize and advance a sustainable pipeline of small molecule kinase inhibitors for the treatment of cancer. Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small-molecule kinase inhibitors for the treatment of cancer.

Corporate Structure

CHIEF EXECUTIVE OFFICER

Scott Salka

TOP EXECUTIVES

Edward Roberts      Board of Directors
Tony Hunter      Board of Directors
M Scott Salka     
Stephen F Keane      Senior Vice President, Corporate Development
Steven A. Elms      Chairman, Managing Director, Perseus, Soros Biopharmaceutical Fund
Hitesh Patel      Head of Discovery Chemistry
Donald R Myll      Chief Financial Officer, Senior Vice President, Commercial Operations
Standish M. Fleming      Board of Directors
Shripad Bhagwat      Senior Vice President, Drug Discovery
Elizabeth Douville      Board of Directors
Patrick P Zarrinkar      Vice President, Technology Development & Alliance Management
Webster Cavenee     
David Armistead      Board of Directors
Kevin J Kinsella     
Nick Lydon      Founder of Granite Biopharma
Linda Robertson      Vice President, Regulatory Affairs & Quality Assurance
Eddie H Shin      Senior Director of Corporate Development
Robert Armstrong      Senior Director of Pharmacology
Kerry Kelly      Vice President and General Counsel
Mark Holladay      Senior Director of Chemistry, Joins Ambit
Wendell Wierenga      Executive Vice President of Research and Development
Charles Zuker      Board of Directors
Allan Marchington      Executive
Antonio J. Grillo-Lopez      Board of Directors
Mark Chee     
R Ian Lennox      Board of Directors
Nicholas Vogelzang      Board of Directors
Mark Levis      Board of Directors
Mark Ratain      Board of Directors
Linda Robinson      Vice President, Regulatory Affairs & Quality Assurance
Gary Gilliland      Board of Directors
Robert Corringham      Senior Vice President, Clinical Development
Edith Perez      Board of Directors
Brian Druker      Board of Directors
Richard Gralla      Board of Directors
Jorge Cortes      Board of Directors